Inhibition of Stress-Inducible Kinase Pathways by Tumorigenic Mutant p53

More than 50% of human cancers contain p53 gene mutations and as a result accumulate altered forms of the full-length p53 protein. Although certain tumor types expressing mutant p53 protein have a poor prognostic process, the precise role of mutant p53 protein in highly malignant tumor cells is not...

Повний опис

Збережено в:

Бібліографічні деталі
Опубліковано в::	Mol Cell Biol
Автори:	Ohiro, Yoichi, Usheva, Anny, Kobayashi, Shinichiro, Duffy, Shannon L., Nantz, Regan, Gius, David, Horikoshi, Nobuo
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Taylor & Francis 2003
Предмети:	Cell Growth and Development
Онлайн доступ:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC140653/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12482984/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/MCB.23.1.322-334.2003
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!

Inhibition of Stress-Inducible Kinase Pathways by Tumorigenic Mutant p53

Схожі ресурси